Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease

Electrolyte Blood Press. 2023 Jun;21(1):24-33. doi: 10.5049/EBP.2023.21.1.24. Epub 2023 Jun 27.ABSTRACTHypertension and potassium imbalance are commonly observed in chronic kidney disease (CKD) patients. The development of hypertension would be related to several mechanisms. Hypertension is related to body mass index, dietary salt intake, and volume overload and is treated with antihypertensives. In CKD patients, managing hypertension can provide important effects that can slow the progression of CKD or reduce complications associated with reduced glomerular filtration rate. The prevalence of hyperkalemia and hypokalemia in CKD patients was similar at 15-20% and 15-18%, respectively, but more attention needs to be paid to treating and preventing hyperkalemia, which is related to a higher mortality rate, than hypokalemia. Hyperkalemia is prevalent in CKD due to impaired potassium excretion. Serum potassium level is affected by renin-angiotensin-aldosterone system inhibitors and diuretics and dietary potassium intake and can be managed by potassium restriction dietary, optimized renin-angiotensin-aldosterone system inhibitor, sodium polystyrene sulfonate, patiromer, and hemodialysis. This review discussed strategies to mitigate and care for the risk of hypertension and hyperkalemia in CKD patients.PMID:37434804 | PMC:PMC10329905 | DOI:10.5049/EBP.2023.21.1.24
Source: Electrolyte and Blood Pressure - Category: Internal Medicine Authors: Source Type: research